Literature DB >> 2849147

Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer.

E M Noordijk1, E vd Poest Clement, J Hermans, A M Wever, J W Leer.   

Abstract

From 1978 to 1983, 50 patients with a peripherally located non-small cell tumor of the lung were irradiated with curative intent. These patients were not operated upon because of poor cardiac or pulmonary condition, old age or refusal to operate. Mean age was 74 years, 40 patients being over 70 years of age. All patients had T1-2 N0M0 tumors according to the AJC classification and received 60 Gy to the primary tumor only. The overall response rate was 90%, with 50% complete responses in tumors smaller than 4 cm. The crude overall survival rates were 56% at 2 years and 16% at 5 years, with a median survival of 27 months. Age did not influence survival. There was a strong correlation of survival to tumor size, with 5-year survival rates of 38, 22, 5 and 0% in tumors with diameters of less than or equal to 2, 2-3, 3-4 and greater than 4 cm respectively. Only 5 out of 20 complete responders had a local recurrence, the 5-year survival in this group was 42%. These results compared favorably to a group of 86 patients over 70 years of age who were selected for operation in the same hospital. The 2- and 5-year survival rates in these patients were 48 and 26% respectively, median survival being 23 months. We conclude that in patients over 70 years of age with resectable lung cancer, radiotherapy with curative intent should be offered as an alternative to operation, especially if the tumor is not larger than 4 cm.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 2849147     DOI: 10.1016/0167-8140(88)90029-1

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  18 in total

1.  Management of lung cancer.

Authors: 
Journal:  BMJ       Date:  1991-01-19

2.  Effect of histologic type on recurrence pattern in radiation therapy for medically inoperable patients with stage I non-small-cell lung cancer.

Authors:  Hitoshi Ishikawa; Yuko Nakayama; Yoshizumi Kitamoto; Tetsuo Nonaka; Hidemasa Kawamura; Katsuyuki Shirai; Hideyuki Sakurai; Kazushige Hayakawa; Hideo Niibe; Takashi Nakano
Journal:  Lung       Date:  2006-11-03       Impact factor: 2.584

Review 3.  Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer?

Authors:  Andrea Riccardo Filippi; Pierfrancesco Franco; Umberto Ricardi
Journal:  Rep Pract Oncol Radiother       Date:  2013-07-01

Review 4.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

5.  Inaccuracy of standard geriatric scores in nonagenarians following hospitalization for various spinal pathologies.

Authors:  Ehab Shiban; Nicole Lange; Paulina Rothlauf; Ann-Kathrin Jörger; Arthur Wagner; Yu-Mi Ryang; Jens Lehmberg; Bernhard Meyer
Journal:  Neurosurg Rev       Date:  2019-06-01       Impact factor: 3.042

Review 6.  Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy?

Authors:  Esengül Koçak Uzel; Ufuk Abacıoğlu
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 7.  [Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients].

Authors:  H Geinitz; F B Zimmermann; M Molls
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

Review 8.  Radiotherapy in the management of non-small-cell lung cancer.

Authors:  A Bezjak; D Payne
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

9.  Video-assisted thoracoscopic wedge resection of T1 lung cancer in high-risk patients.

Authors:  H A Shennib; R Landreneau; D S Mulder; M Mack
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

10.  Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer.

Authors:  Juan P Wisnivesky; Ethan Halm; Marcelo Bonomi; Charles Powell; Emilia Bagiella
Journal:  Am J Respir Crit Care Med       Date:  2009-11-05       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.